Real-world effectiveness and safety of olaparib in HRD-positive BRCA wild-type ovarian cancer

Ovarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm with the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, which are now standard in the maintenance setting following first-line chemotherapy.

Keto Diet on Par With Further Medication for Infants With Drug-Resistant Epilepsy

A ketogenic diet was similar in efficacy and tolerability to further anti-seizure medication for infants with drug-resistant epilepsy, a randomized clinical trial in the U.K.

December 15, 2023

Smileyscope Receives FDA Clearance for First-Ever VR Analgesic

What You Should Know: – Smileyscope™, a pioneer in virtual reality (VR) therapeutic solutions, has received Class II clearance from the U.S. Food and Drug

December 9, 2023

‘Faster together’: AstraZeneca breaks into clinical services business with new company launch, lining up two CRO partners to start

LONDON — AstraZeneca has launched a new global health tech business, Evinova, after seeing a gap in the market to reduce the time and cost

November 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.